Ezose Sciences Enters Glycomics Research Agreement with Kyowa Hakko Kirin
Complete the form below to unlock access to ALL audio articles.
Ezose Sciences Inc. announced that it has entered a research agreement with Kyowa Hakko Kirin Co. Ltd. to collaborate on glycomics studies using Ezose’s proprietary GlycanMap® technology platform.
Under terms of the research agreement, Kyowa Hakko Kirin will fund several glycan-biomarker and other discovery projects, with an option for further research and development. Other details of the agreement were not disclosed.
“We look forward to putting our unique glycan-analysis capabilities to the service of the specific research interests of Kyowa Hakko Kirin,” said Hidehisa Asada, Ph.D., Vice President, Research & Development of Ezose. “As the structure of our collaboration anticipates, the research will seek new discoveries that enable novel therapeutic strategies and sustain the flow of new products to market.”